Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s Guidance Document To-Do List

03 Jan 2011

Related Content

FDA's Internet Promotion Policy: Christmas Cards In Lieu Of Guidance?

03 Jan 2011

FDA's Seyfert-Margolis On Companion Diagnostics Guidance

08 Nov 2010

FDA Drug Development Tool Guidance Leaves Door Open For Advisory Committee Reviews

15 Nov 2010

FDA Standardizing “Dear Doc” Letters To Fix Problems With Recipients As Much As Senders

29 Nov 2010

INDs Needed For Some Comparative Effectiveness Research, FDA Suggests

01 Nov 2010

Non-Inferiority Studies May (Bio)Creep Out Of Limelight After GAO Report

06 Sep 2010

FDA May Allow "Qualitative" Labels For Data In DTC Ads

31 Aug 2010

DDMAC, Soon To Be An Office, Hones In On DTC Advertising

25 Oct 2010

FDA IND Safety Reporting Rule: New Types Of Data Must Be Submitted

04 Oct 2010

FDA Finds “Comfort Level” With Using Medicare Data For Sentinel Initiative

11 Oct 2010

Adaptive Trials Could Have A Steep Regulatory Learning Curve

08 Mar 2010

FDA Issues Co-Development Guidance, But Only For Products Treating "Serious" Diseases

14 Dec 2010

Dangerous Clutter: FDA Takes On Errors Caused By Drug Labels, Packaging

05 Jul 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.